Femtech in the Spotlight — An Interview with Wolfgang Hackl — Founder and CEO of OncoGenomX
July 11, 2022
联系人
随时了解最新情况
Eva von Mühlenen (Advisor, Geneva) and Josefine Sommer (Senior Managing Associate, Brussels) interviewed Wolfgang Hackl, founder of OncoGenomX, a Femtech startup that guides doctors in the treatment of breast cancer — about regulation, research and development (R&D), and the vast potential of artificial intelligence in the field of health technology for women.